Regulatory T (T~reg~) cells safeguard against autoimmunity and overshooting inflammation. During their development in the thymus, T~reg~ cells are selected by stronger autoantigenic T cell receptor (TCR) signals than conventional T cells. These TCR signals are critically important for the initiation of two key lineage defining events, namely induction of the transcription factor Foxp3 and hypomethylation of a specific gene set. Recent studies shed light on the role of continuous (autoreactive) TCR signals for identity, homeostasis and functions of mature T~reg~ cells.

Induced TCR ablation on mature T~reg~ cells only minimally reduces Foxp3 expression \[[@R1], [@R2]\] and does not affect hypomethylation patterns \[[@R1]\]. Stable Foxp3 expression was also observed in T~reg~ cells lacking the TCR signal transduction proteins Lck \[[@R3]\] or SLP-76 \[[@R4]\] and upon ablation of the co-stimulatory receptor CD28 \[[@R5]\]. Fittingly, mature T~reg~ cells, expressing a TCR but deprived of peripheral autoantigenic stimulation due to lack of MHC II on hematopoietic cells, still express Foxp3 \[[@R6]\]. Therefore, once a core T~reg~ cell identity has been established in the thymus, it is maintained independently of peripheral TCR signals.

In contrast, the T~reg~ cell surface phenotype and their signature gene expression were strongly affected by the various means of inhibiting TCR signals \[[@R1]--[@R3], [@R6]\]. However, the peripheral T~reg~ cell pool is heterogeneous in that it consists of naïve and various subsets of effector-like T~reg~ cells. Induced TCR ablation showed that, at least under homeostatic conditions in healthy mice, effector-like T~reg~ cells strictly depend on TCR signals for their generation and/or maintenance. Attempts to distinguish between naïve and effector-like T~reg~ cells based on CD62L/CD44 \[[@R2]\] or CD25 \[[@R1]\] expression revealed that both require TCR signals to maintain their characteristic surface phenotype and gene expression, independently of their homeostasis. Interestingly, apart from reduced levels of TCR-activated transcription factors such as Egr2 and c-Rel and their respective target genes, loss of TCR signals strongly affects IRF4-controlled genes. The concept that DNA hypomethylation ensures the expression of key T~reg~ cell genes is supported by the reduced, but still robust expression of CTLA-4, GITR and Eos of TCR-deficient T~reg~ cells \[[@R1]\].

Both induced TCR and co-stimulatory CD28 ablation cause a decline in T~reg~ cells in the absence of thymic T cell production, which goes hand in hand with completely abrogated \[[@R1]\] or reduced \[[@R5]\] homeostatic proliferation, respectively. This is not due to reduced responsiveness to homeostatic cytokines, such as IL-2. Interestingly, T~reg~ cells deprived of MHC II contact proliferate well in response to anti-CD3 stimulation \[[@R6]\] and TCR-deficient T~reg~ cells divide when stimulated with TCR-bypassing PMA/Ionomycin \[[@R2]\], indicating that these cells do not become anergic to proliferation-inducing signals. The protein levels of Bcl-2 and Bim are two-fold upregulated in T~reg~ cells upon TCR loss, to the same levels as in naïve CD4 T cells \[[@R1]\]. However, none of the studies reported a significant difference in survival between TCR signaling impaired and normal T~reg~ cells *in vivo*, and BrdU pulse-chase experiments suggest impaired turn-over/proliferation, but normal survival of Lck-deficient T~reg~ cells \[[@R3]\]. Collectively, these experiments show that TCR signal-induced proliferation forms an essential homeostatic requirement for all T~reg~ cell subsets.

T~reg~ cells suppress immune responses through the release of inhibitory cytokines, competition for IL-2, access to and functional modulation of antigen presenting cells and direct cytotoxic killing. TCR-deficient T~reg~ cells show reduced expression of inhibitory and cytotoxic molecules including IL-10 and Granzyme B. In addition, the expression of proteins through which T~reg~ cells regulate the functions of antigen presenting cells, such as CTLA-4, NT5E/CD73, LFA-1 and NRP1, is significantly reduced \[[@R1], [@R2], [@R6]\]. TCR signaling impaired T~reg~ cells fail to efficiently suppress T cell activation and proliferation *in vitro* \[[@R3]--[@R6]\]. Conversely, augmenting TCR signaling by ablating the DAG-metabolizing kinase DGKζ enhances the *in vitro* suppression capacity \[[@R4]\]. Importantly, T~reg~ cells require constant TCR signals to sustain their suppressive abilities *in vivo*: MHC II contact-deprived T~reg~ cells fail to control naïve T cell expansion upon co-transfer \[[@R6]\], TCR-deficient T~reg~ cells cannot control effector T cell differentiation/proliferation and cytokine production *in situ* \[[@R2]\] and induced TCR ablation limits T~reg~ cell-mediated control of colitis and EAE \[[@R1]\]. Therefore, TCR signals continuously arm T~reg~ cells for suppression, in addition to their role in their homeostasis.

Expression height of Ly-6C, which is strongly elevated in Lck-deficient \[[@R3]\] and TCR-deficient \[[@R1]\] T~reg~ cells, appears to differentiate T~reg~ cells receiving strong TCR signals (Ly-6C−) from those that do not (Ly-6C+) \[[@R7]\]. Purified Ly-6C− and Ly-6C+ T~reg~ cells differed dramatically in phenotype, gene expression and their ability to suppress *in vitro* and *in vivo*. Accordingly, effector T~reg~ cells are exclusively Ly-6C−. However, on average half of the TCR-deficient T~reg~ cells lacked Ly-6C (Vahl et al., unpublished), showing that not all Ly-6C− T~reg~ cells result from continuous TCR triggering. Modern multiparameter flow cytometry should help to further unravel the dynamic complexities of T~reg~ cell subsets.

In summary, we conclude that while TCR signals are dispensable for maintaining the core T~reg~ cell identity, they are continuously fueling their homeostasis, effector differentiation and suppressive functions.
